You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • OP0167 Efficacy and safety of CNTX-4975 in subjects with moderate to severe osteoarthritis knee pain: 24-week, randomized, double-blind, placebo-controlled, dose-ranging study

Article metrics

Article menu

Download PDFPDF

Oral Presentations
Osteoarthritis: new horizons for treatment
OP0167 Efficacy and safety of CNTX-4975 in subjects with moderate to severe osteoarthritis knee pain: 24-week, randomized, double-blind, placebo-controlled, dose-ranging study
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20172203
Jul 201712203
Aug 20174003
Sep 20172603
Oct 20172001
Nov 20173103
Dec 20172900
Jan 20189107
Feb 20182801
Mar 20185205
Apr 20188800
May 20184001
Jun 20184601
Jul 20186801
Aug 20183201
Sep 20182002
Oct 201872011
Nov 20182206
Dec 20182809
Jan 20191501
Feb 20193009
Mar 20193209
Apr 20192806
May 201944010
Jun 20192801
Jul 20193505
Aug 201944010
Sep 20191601
Oct 20191803
Nov 20191402
Dec 20192605
Jan 20201202
Feb 20201901
Mar 20203006
Apr 2020401
May 20201403
Jun 20202206
Jul 20203006
Aug 2020203
Sep 20203804
Oct 20202807
Nov 20202806
Dec 20202205
Jan 20211204
Feb 2021407
Mar 20211603
Apr 20211801
May 2021505
Jun 2021002
Jul 2021007
Aug 2021201
Sep 2021106
Oct 202120021
Nov 202127012
Dec 202119011
Jan 2022904
Feb 20221601
Mar 20224705
Apr 20221204
May 202239011
Jun 20225805
Jul 20222001
Aug 202225010
Sep 2022609
Oct 20222807
Nov 2022807
Dec 20221701
Jan 20233701
Feb 20231903
Mar 20233802
Apr 20232203
May 20232308
Jun 20231000
Jul 20231607
Aug 20231004
Sep 20231204
Oct 20233201
Nov 20234003
Dec 20232403
Jan 20241802
Feb 20241601
Mar 20241701
Total21990361